BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31775111)

  • 21. Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2.
    Hornyak P; Askwith T; Walker S; Komulainen E; Paradowski M; Pennicott LE; Bartlett EJ; Brissett NC; Raoof A; Watson M; Jordan AM; Ogilvie DJ; Ward SE; Atack JR; Pearl LH; Caldecott KW; Oliver AW
    Biochem J; 2016 Jul; 473(13):1869-79. PubMed ID: 27099339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of assays and antibodies to facilitate the study of human 5'-tyrosyl DNA phosphodiesterase.
    Thomson G; Watson A; Caldecott K; Denneny O; Depledge P; Hamilton N; Hopkins G; Jordan A; Morrow C; Raoof A; Waddell I; Ogilvie D
    Anal Biochem; 2013 May; 436(2):145-50. PubMed ID: 23416181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of TDP2 on the Level of TOP2-DNA Complexes and SUMOylated TOP2-DNA Complexes.
    Lee KC; Swan RL; Sondka Z; Padget K; Cowell IG; Austin CA
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivating TDP2 missense mutation in siblings with congenital abnormalities reminiscent of fanconi anemia.
    Zagnoli-Vieira G; Brazina J; Van Den Bogaert K; Huybrechts W; Molenaers G; Caldecott KW; Van Esch H
    Hum Genet; 2023 Sep; 142(9):1417-1427. PubMed ID: 37558815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of DNA damage induced Topoisomerase 2 DNA-protein crosslinks by Tdp2.
    Schellenberg MJ; Perera L; Strom CN; Waters CA; Monian B; Appel CD; Vilas CK; Williams JG; Ramsden DA; Williams RS
    Nucleic Acids Res; 2016 May; 44(8):3829-44. PubMed ID: 27060144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoquinoline-1,3-diones as Selective Inhibitors of Tyrosyl DNA Phosphodiesterase II (TDP2).
    Kankanala J; Marchand C; Abdelmalak M; Aihara H; Pommier Y; Wang Z
    J Med Chem; 2016 Mar; 59(6):2734-46. PubMed ID: 26910725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-Wide CRISPR Screens Reveal ZATT as a Synthetic Lethal Target of TOP2-Poison Etoposide That Can Act in a TDP2-Independent Pathway.
    Park JM; Zhang H; Nie L; Wang C; Huang M; Feng X; Tang M; Chen Z; Xiong Y; Lee N; Li S; Yin L; Hart T; Chen J
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Deoxycholic Acid Derived Tyrosyl-DNA Phosphodiesterase 1 Inhibitors Also Inhibit Tyrosyl-DNA Phosphodiesterase 2.
    Salomatina OV; Dyrkheeva NS; Popadyuk II; Zakharenko AL; Ilina ES; Komarova NI; Reynisson J; Salakhutdinov NF; Lavrik OI; Volcho KP
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo.
    Gómez-Herreros F; Romero-Granados R; Zeng Z; Alvarez-Quilón A; Quintero C; Ju L; Umans L; Vermeire L; Huylebroeck D; Caldecott KW; Cortés-Ledesma F
    PLoS Genet; 2013; 9(3):e1003226. PubMed ID: 23505375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TDP2 suppresses genomic instability induced by androgens in the epithelial cells of prostate glands.
    Al Mahmud MR; Ishii K; Bernal-Lozano C; Delgado-Sainz I; Toi M; Akamatsu S; Fukumoto M; Watanabe M; Takeda S; Cortés-Ledesma F; Sasanuma H
    Genes Cells; 2020 Jul; 25(7):450-465. PubMed ID: 32277721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-Benzylideneisoquinoline-1,3(
    Senaweera S; He T; Cui H; Aihara H; Wang Z
    Med Chem Res; 2021 Feb; 30(2):371-386. PubMed ID: 33776385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and TOP2.
    Marzi L; Sun Y; Huang SN; James A; Difilippantonio S; Pommier Y
    Mol Cancer Ther; 2020 Aug; 19(8):1589-1597. PubMed ID: 32430490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors.
    Zakharova O; Luzina O; Zakharenko A; Sokolov D; Filimonov A; Dyrkheeva N; Chepanova A; Ilina E; Ilyina A; Klabenkova K; Chelobanov B; Stetsenko D; Zafar A; Eurtivong C; Reynisson J; Volcho K; Salakhutdinov N; Lavrik O
    Bioorg Med Chem; 2018 Aug; 26(15):4470-4480. PubMed ID: 30076000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors.
    Huang SN; Pommier Y; Marchand C
    Expert Opin Ther Pat; 2011 Sep; 21(9):1285-92. PubMed ID: 21843105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usnic Acid Derivatives Inhibit DNA Repair Enzymes Tyrosyl-DNA Phosphodiesterases 1 and 2 and Act as Potential Anticancer Agents.
    Zakharenko AL; Dyrkheeva NS; Luzina OA; Filimonov AS; Mozhaitsev ES; Malakhova AA; Medvedev SP; Zakian SM; Salakhutdinov NF; Lavrik OI
    Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).
    Pommier Y; Huang SY; Gao R; Das BB; Murai J; Marchand C
    DNA Repair (Amst); 2014 Jul; 19():114-29. PubMed ID: 24856239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1.
    Dyrkheeva NS; Filimonov AS; Luzina OA; Orlova KA; Chernyshova IA; Kornienko TE; Malakhova AA; Medvedev SP; Zakharenko AL; Ilina ES; Anarbaev RO; Naumenko KN; Klabenkova KV; Burakova EA; Stetsenko DA; Zakian SM; Salakhutdinov NF; Lavrik OI
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary metabolites from Isodon ternifolius (D. Don) Kudo and their anticancer activity as DNA topoisomerase IB and Tyrosyl-DNA phosphodiesterase 1 inhibitors.
    Zhang HL; Zhang Y; Yan XL; Xiao LG; Hu DX; Yu Q; An LK
    Bioorg Med Chem; 2020 Jun; 28(11):115527. PubMed ID: 32345458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II.
    Raoof A; Depledge P; Hamilton NM; Hamilton NS; Hitchin JR; Hopkins GV; Jordan AM; Maguire LA; McGonagle AE; Mould DP; Rushbrooke M; Small HF; Smith KM; Thomson GJ; Turlais F; Waddell ID; Waszkowycz B; Watson AJ; Ogilvie DJ
    J Med Chem; 2013 Aug; 56(16):6352-70. PubMed ID: 23859074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Dual Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 and 2 Based on Deoxycholic Acid: Design, Synthesis, Cytotoxicity, and Molecular Modeling.
    Salomatina OV; Kornienko TE; Zakharenko AL; Komarova NI; Achara C; Reynisson J; Salakhutdinov NF; Lavrik OI; Volcho KP
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.